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We used molecular genotyping to further understand the epidemiology and transmission patterns of tuber-
culosis (TB) in Massachusetts. The study population included 983 TB patients whose cases were verified
by the Massachusetts Department of Public Health between July 1, 1996, and December 31, 2000, and for
whom genotyping results and information on country of origin were available. Two hundred seventy-two
(28%) of TB patients were in genetic clusters, and isolates from U.S-born were twice as likely to cluster as
those of foreign-born (odds ratio [OR] 2.29, 95% confidence interval [CI] 1.69 to 3.12). Our results suggest
that restriction fragment length polymorphism analysis has limited capacity to differentiate TB strains when
the isolate contains six or fewer copies of IS6110, even with spoligotyping. Clusters of TB patients with
more than six copies of IS6110 were more likely to have epidemiologic connections than were clusters of
TB patients with isolates with few copies of IS6110 (OR 8.01, 95%; CI 3.45 to 18.93). 
he incidence of tuberculosis (TB) in the United States is
closely linked to the global TB epidemic (1). In 2000,
46% of all reported TB cases in the United States occurred
among persons not born in the United States (foreign-born),
and 20 states reported that >50% of TB cases occurred among
the foreign-born (2). In Massachusetts, 202 (71%) of 285 cases
reported were among foreign-born persons (from 41 different
countries). Being born outside the United States is the primary
risk factor for being reported with TB in Massachusetts (3). 
The distribution of places of birth among TB patients
reported in Massachusetts has changed greatly over the past 3
decades, reflecting changes in populations immigrating to
Massachusetts. As late as 1970, 80% of foreign immigrants in
Massachusetts were from Europe or Canada; only 5% of the
immigrants were from Asia, and less than 3% were from Cen-
tral and South America combined and Africa (4). Since 1970,
the proportion of immigrants to Massachusetts from Europe
has declined, and the proportion of those from Asia, the Carib-
bean Islands, Africa, and South and Central America has risen.
Immigrants from Asia increased sharply, from 3% to 16%.
Between 1996 and 2000, the proportion of foreign-born TB
patients reported in Massachusetts rose from 61% to72%. This
increase was seen primarily among Asians, Africans, and
immigrants from Central and South America. 
Understanding the factors that contribute to the incidence
of TB is critical for TB elimination. Molecular fingerprinting
data can be used to further an understanding of the epidemiol-
ogy and transmission patterns of TB. In this article, we
describe the epidemiology of TB patients in Massachusetts
and results of using genotyping to evaluate the extent to which
genetic clustering of Mycobacterium  tuberculosis differs
between foreign-born and U.S.-born TB patients.
Methods
In 1996, the Massachusetts Department of Public Health,
Division of Tuberculosis Prevention and Control (TB Divi-
sion) became part of the Centers for Disease Control and Pre-
vention (CDC)’s National Tuberculosis Genotyping and
Surveillance Network. The TB Division attempted to locate
and submit at least one isolate for every culture-confirmed TB
case-patient reported from July 1, 1996, through December 31,
2000, to the Northeast Regional Genotyping Laboratory, New
York State Department of Health, Wadsworth Center, Albany,
New York. DNA genotyping by using IS6110 restriction frag-
ment length polymorphism (RFLP) and the spoligotyping
technique (spacer oligotyping) was performed by the Wad-
sworth Center. RFLP analysis was performed by using the
standard method (5,6) with the molecular weight standards
provided by CDC. Spoligotyping was performed with a com-
mercially available kit, in accordance with the manufacturer’s
instructions (Isogen Bioscience BV, Maarseen, the Nether-
lands). 
Specimen Collection for DNA Fingerprinting Analysis
The following procedures were used to identify patients
with positive Mycobacterium tuberculosis cultures and obtain
isolates for RFLP analysis. In 1996, a survey of hospitals and
private physicians was conducted to ascertain where speci-
mens were being sent for mycobacterial culture. This survey
allowed the TB Division to determine which laboratories
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inside and outside of the state were processing clinical speci-
mens for Massachusetts residents. In addition, a letter was sent
to directors of all laboratories in Massachusetts that are
licensed under the Clinical Laboratory Improvement Act
(CLIA) to perform mycobacteriology services and to other
laboratories that were identified through the survey, asking for
their cooperation with the TB genotyping network project.
Most (71%) hospitals and physicians sent specimens to the
Massachusetts State Laboratory Institute (MSLI) for culture
identification, susceptibility testing, or both. The TB Division
and the Mycobacteriology Laboratory, MSLI, share a joint
database where all bacteriology reports, including drug sus-
ceptibility information, are automatically linked to suspected
and confirmed cases of TB. For M. tuberculosis specimens that
were processed elsewhere, the epidemiologists on the TB
genotyping network project identified laboratories by attend-
ing routine TB case and cohort reviews conducted monthly by
the state TB nurses and the Boston Public Health Commission
TB Program. Laboratories were then contacted and arrange-
ments were made for shipment of specimens to the MSLI and
the Wadsworth Center. 
Cluster Investigation
RFLP analysis by using IS6110 is a powerful tool for dis-
cerning one strain of M. tuberculosis from another when there
are many copies of IS6110. However, for strains of M. tuber-
culosis with low copy numbers of IS6110, RFLP analysis has
less discriminating power, and therefore a secondary typing
method is used to help differentiate strains (7,8). For the TB
genotyping network project, isolates were considered to be
clonally related (i.e., were the same strain of TB) if they had
identical IS6110 patterns containing seven or more bands or
they had identical IS6110  patterns containing six or fewer
bands with identical spoligotyping. A cluster was defined as
containing two or more patients with clonally related TB
strains. 
In 1998, CDC funded the Cluster Investigation Study to
evaluate epidemiologic links between clustered cases in a
more formal manner. Cluster investigations consisted of stan-
dardized medical record reviews wherever a patient was seen
for TB, and standardized interviews with the patient (or a
proxy) if the patient was unable to participate. All patients
were eligible for interview, unless strong epidemiologic links
were found between all members of the cluster. In that situa-
tion, interviews were considered unnecessary. Written
informed consent was obtained from all subjects, and inter-
preters were used as needed. Information collected through
medical record reviews and patient interviews included the
estimated period of infectivity, demographics, employment
history, and social connections and activities during the 2 years
before diagnosis. Each patient in a genetic cluster was exam-
ined to determine the following: 1) the period of infectivity (by
reviewing date of diagnosis, disease type, smear status, chest
radiology results, and date treatment started), 2) name of con-
tacts identified, and 3) how and where the patient spent his or
her time during the period of infectivity. If a patient identified
another patient in the same cluster, or if patients were found to
be in the same place at the same time when one was infectious,
the likelihood of transmission was classified as “definite.”
Transmission was “possible” if patients were thought to be at
the same place, at the same time up to 2 years before diagno-
sis, or if patients identified the same contact as being the
source of TB. A final category, “unlikely,” was designated
when no common place or other epidemiologic connection
was identified or when patients had arrived so recently in the
country that transmission was unlikely to have occurred. Fur-
ther details about the formal cluster investigation study are
provided elsewhere (9). Data were analyzed by using Epi Info
version 6.03 (10). The study was reviewed and approved by
the, Human Research Review Committee, Massachusetts
Department of Public Health.
Results
Epidemiology of TB in Massachusetts and Genotypes
From July 1, 1996, to December 31, 2000, a total of 1,281
cases were reported and verified as TB by the TB Division, of
which 1,032 (81%) were confirmed with positive culture for
M. tuberculosis. Genotype results were obtained for 984 (95%)
of the culture confirmed cases. For the remaining 48 cases,
genotype results were not obtained for a variety of reasons,
including inability to obtain M. tuberculosis isolates from pri-
vate laboratories and too little growth on culture. Of the 984
TB patients for whom DNA fingerprinting results were
obtained, epidemiologic analyses were conducted for 983
patients whose country of origin was known. The greatest risk
for developing TB in Massachusetts was being born outside
the United States.
Six hundred eighty four (70%) of the TB patients were for-
eign-born (from 78 different countries). Most (295; 43%) for-
eign-born patients were from Asia, followed by the Caribbean
region (118;17%) and Africa (116;17%). Countries with the
highest number of cases included: Vietnam: 87 cases (13%);
Haiti, 83 (12%); China, 59 (9%), India, 54 (8%); Cambodia,
31 (5%), and the Dominican Republic, 30 (4%). Analyses of
intervals between arrival into the United States and diagnosis
of TB indicated that 176 (26%) patients were diagnosed with
TB within 1 year of arrival and 353 (52%) were diagnosed
with TB within 5 years of arrival (Table 1).
Foreign-born patients were likely to be younger than U.S.-
born TB patients (Table 2). Three hundred twenty-seven
(48%) of the foreign-born patients were ages 25–44, as com-
pared to 75 (25%) of U.S.-born patients; 103 (15%) of foreign-
born patients were >65 years, as compared with 108 (36%) of
U.S.-born patients. Foreign-born patients were also more
likely to have extrapulmonary disease: 232 (34%) of foreign-
born patients had extrapulmonary TB compared with 61 (20%)
of U.S.-born patients. TB patients born in the United States
were more likely to have been homeless within the year before
diagnosis, and drug use and excessive alcohol use were higherEmerging Infectious Diseases  •  Vol. 8, No. 11, November 2002 1241
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among U.S.-born patients than among foreign-born TB
patients. Definition of drug use (injecting drug use and nonin-
jecting drug use), homelessness, and excessive alcohol use are
based on CDC criteria as contained in the instruction for the
completion of the CDC TB cases reporting forms (11).
Distribution of Genotypes
Analyses of RFLP distribution indicated that 208 (21%)of
983 isolates contained six or fewer copies of IS6110. Sixty-
seven (22%) of the isolates from 299 U.S.-born TB patients
contained few copies of IS6110, as did 141 (21%) of the 684
isolates from foreign-born TB patients. However, isolates from
foreign-born patients differed substantially by geographic
region and country of birth (Table 3).One hundred one (34%)
of isolates from Asian patients contained few copies of IS6110
compared with 2 (4%) of isolates from persons born in South
America. In addition, 42 (48%) of isolates from Vietnam con-
tained few copies of IS6110  compared with 7 (12%) from
China. 
Genetic Clustering of TB Cases by Genotyping
Of isolates from 983 TB patients, 711 (72%) had DNA fin-
gerprints unique among Massachusetts isolates. The remaining
272 (27.7%) were in 82 genetic clusters. However, 171 (22%)
of the 775 isolates containing more than six copies of IS6110
were in genetic clusters as compared to 100 (48%) of the 208
isolates containing few copies of IS6110. Of the 208 isolates,
158 (76%) clustered by IS6110 alone; 100 (48%) of the iso-
lates remained clustered even with the addition of spoligotyp-
ing data to further differentiate the TB strain. The genetic
clusters were relatively small in size; 52 (63%) of 82 clusters
contained only 2 people, 25 clusters (30%) contained 3–5 peo-
ple, and the largest cluster contained 16 people. Among the
299 U.S.-born TB patients, 119 (40%) patients had isolates in
genetic clusters; 180 (60%) of those had isolates with a unique
fingerprint. These figures compare with 153 (22%) of the 684
foreign-born TB patients who had isolates in genetic clusters
and 531 (78%) who had unique fingerprints. U.S.-born TB
patients were more likely to cluster than foreign-born TB
patients (odds ratio [OR] 2.29, 95% confidence interval [CI]
1.69 to 3.12). Foreign-born patients who had lived longer in
the United States were more likely to have isolates that clus-
tered than were recent arrivals (chi square for trend 6.31,
p<0.05). Overall, 29 (16%) of those diagnosed with TB within
1 year of arrival had isolates that clustered with others as com-
pared to 38 (22 %) among those diagnosed from 1 to 5 years of
arrival and 26% among those diagnosed >5 years after arrival
(Table 4). Stratified analyses by age group (<25, 25–44, 45–
64, >65) indicated that clustering was associated with
increased time spent in the United States for all age groups;
however, the association was strongest among those 25–44
years of age (p<0.05). 
Likelihood of Epidemiologic Link 
among Clustered TB Cases
Although the TB genotyping network was started in 1996,
cluster investigation did not formally begin until 1998. There-
fore, of the 272 patients found in 82 clusters overall, only 161
patients in 52 clusters were investigated for epidemiologic
connections as part of the formal Cluster Investigation Study.
Information regarding epidemiologic connections was
obtained for 152 (94%) of 161 patients. Epidemiologic con-
nections were established for 68 (45%) of the 152 clustered
TB cases, but none were found for 84 (55%) of the clustered
TB cases. Epidemiologic connections were more likely to be
identified for clusters containing only U.S.-born TB patients
than clusters containing some or all foreign-born TB patients
(62% vs. 42% and 33%, respectively; chi square for trend,
p<0.05). In addition, clustered TB patients with many copies
of IS6110 were more likely to have epidemiologic connections
than clusters with few copies of IS6110 (OR 8.01; 95% CI
3.45 to 18.93). Of the 90 clustered TB isolates with many cop-
ies of IS6110, 57 (63%) had epidemiologic connections identi-
fied, compared with the 11 (18%) epidemiologic connections
that were identified among the 62 clustered TB case-patients
with few copies of IS6110. Among the U.S.-born patients, 26
(79%) of the 33 patients with many copies of IS6110 had defi-
nite or possible epidemiologic connections, whereas none of
the 9 patients with few copies of IS6110  had connections
(Table 5).
Of the 152 clustered TB patients, 42 (28%) were in clus-
ters containing only U.S.-born patients, 67 (44%) were in clus-
ters with mixed U.S.-born and foreign-born patients, and 43
(28%) were in clusters containing only foreign-born patients.
Analysis of the 67 TB patients in mixed clusters containing
both U.S.-born and foreign-born persons indicate that 38
(57%) of the TB patients were foreign-born, and 29 (43%)
were U.S.-born. Epidemiologic connections were established
Table 1. Tuberculosis (TB) cases in foreign-born persons by number of years in the United States, by geographic region
Time from arrival in the 
United States to TB diagnosis  Asia (%) Caribbean (%) Africa (%) Europe (%)
South 
America (%)
Central 
America (%)
Former Soviet 
Union (%) Othera(%) Total (%)
<1 year 64 (22) 24 (21)  47 (41) 10 (29) 16 (34) 9 (22) 6 (27) 0 176 (26)
1–5 years 62 (21) 25 (21) 51 (44) 2 (6) 17 (36) 15 (37) 5 (23) 0 177 (26)
6–10 years 66 (22) 18 (15) 14 (12) 2 (6) 7 (15) 10 (24) 5 (23) 1 (12) 123 (18)
>10 years 103(35) 51 (43) 4 (3) 23 (62) 7 (15) 7 (17) 6 (27) 7 (88) 208 (30)
Total (n=684) 295 (43) 118 (17) 116 (17) 37 (5) 47 (7) 41 (6) 22 (3) 8 (1) 684 (100)
aOther, 7 patients from Canada and 1 patient from Australia.TUBERCULOSIS GENOTYPING NETWORK
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for 28 (42%) of the 67 TB patients in mixed clusters, and the
17 resulting relationships were analyzed to determine the
direction of TB transmission between the cluster members.
Results indicate that TB was transmitted from foreign-born to
U.S.-born persons in 6 (35%) relationships, foreign-born to
foreign-born persons in five (29%) relationships, U.S.-born to
U.S.-born persons in three (18%) relationships and U.S.-born
to foreign-born persons in three (18%) relationships. However,
three of the six foreign-born to U.S.-born relationships
involved children of foreign-born parents born in the United
States. Epidemiologic relationships were established for 26
(62%) of the 42 TB patients in clusters containing only U.S.-
born persons, resulting in 20 relationships. Of the 43 TB
patients in clusters containing only foreign-born persons, epi-
demiologic connections were established for 14 patients
(33%), resulting in eight relationships. Overall, of the 45 rela-
tionships established through the 68 clustered TB patients with
epidemiologic connections, possible TB transmission between
U.S.-born persons occurred in 23 (51%) relationships, from
foreign-born to foreign-born persons in 13 (29%) relation-
ships, from foreign-born to U.S.-born in 6 (13%) relationships
and from U.S.-born to foreign-born in 3 (7%) relationships. In
addition, of the 38 foreign-born TB patients in mixed U.S.-
born and foreign-born clusters, 10 (26%) TB was diagnosed
within 1 year of arrival, in 7 (18%), TB was diagnosed from 1–
5 years of arrival, and among 21 (55%), TB was diagnosed > 5
years after the person arrived in the United States. However,
TB patients in mixed clusters were no more likely than
patients in clusters containing only foreign-born persons to be
diagnosed with TB within 1 year, from 1–5 years, or >5 years
of arrival (chi square for trend 0.038, p=0.85). 
Discussion
The greatest risk of developing TB in Massachusetts is
being foreign-born. This finding is consistent with the results
found by Mitnick et al., indicating that the foreign-born were
Table 2. Demographic characteristics of U.S.-born and foreign-born tuberculosis (TB) case-patientsa
Demographics Foreign-born (%) n=684 U.S.-born (%) n=299 Odds ratio and 95% confidence interval (CI) p value
Sex
Male 380 (56) 183 (61) 0.80 (95% CI 0.60, 1.06) p=0.11
Female 304 (44) 117 (39)
Age groupb
<1–24 106 (16) 23 (8) 1.0
25–44 327 (48) 75 (25) 1.06 (95% CI 0.61,1.83) p=0.83
45–64 148 (22) 93 (31) 2.90 (95% CI 1.67,5.04) p<0.01
>65 103 (15) 108 (36) 4.83 (95% CI 2.77,8.47) p<0.01
Site of diseaseb
Pulmonary 452 (66) 238 (80) 0.50 (95 %CI 0.36,0.70) p<0.01
Extrapulmonary 232 (34) 61 (20)
HIV status
Positive 59 (9) 31 (10) 0.75 (95% CI 0.44,1.30) p= 0.28
Negative 177 (26) 70 (23)
Unknown 449 (66) 198 (66)
Homeless in past yearb
Yes 16 (2) 38 (13) 0.16 (95% CI 0.09,0.31)  p<0.01
No 666 (97) 258 (86
Unknown 2 (<1) 3 (1)
Drug use in past yearb,c
Yes 6 (<1) 27 (9) 0.08 (95% 0.03,0.21) p<0.01
No 611 (89) 221 (74)
Unknown 67 (10) 51 (17)
Excessive alcohol use in past yearb 
Yes 34 (5) 74 (25) 0.14 (95% CI 0.09,0.22) p<0.01
No 577 (84) 176 (59)
Unknown 73 (11) 49 (16)
aDefinitions of homeless, dug use and alcohol use are based on criteria established by the Centers for Disease Control and Prevention.
b Significant difference observed between U.S.-born and foreign-born at p<0.01. 
cIncludes both injecting and noninjecting drug users.Emerging Infectious Diseases  •  Vol. 8, No. 11, November 2002 1243
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7.5 times more likely to have TB than U.S.-born residents of
this state (3). An analysis of time from arrival to TB diagnosis
indicated that among 26%,TB was diagnosed within 1 year of
arrival and among another 26%, it was diagnosed from 1 to 5
years of arrival. This increased risk soon after arrival is partic-
ularly true for persons arriving from Africa and South Amer-
ica, among whom TB was diagnosed within 1 year of their
arrival for 41% and 35%, respectively. In Massachusetts, the
TB Division is notified of refugees and immigrants with a
class A or B TB condition identified through the overseas
screening process. Together with the Massachusetts Refugee
and Immigrant Health Program, the TB Division works to
ensure that those refugees and immigrants are evaluated for
active TB soon after their arrival in the United States. How-
ever, most foreign-born persons moving into Massachusetts
are not refugees or immigrants but students or tourists, and
therefore the TB Division has little or no information that
would allow targeted TB screening. 
Only 28% of Massachusetts TB patients had M. tuberculo-
sis isolates that were clonally related. Most TB cases were
likely the result of reactivation of old infection or recent infec-
tion that occurred in the person’s country of origin, rather than
new infection acquired in this state.. U.S.-born patients were
twice as likely to cluster as foreign-born TB patients, suggest-
ing that transmission may be occurring more in the U.S.-born
population. U.S.-born TB patients were significantly more
likely than foreign-born patients to have a communicable form
of TB disease, which may be one more explanation for the
increase in clustering among U.S.-born patients. TB transmis-
sion between foreign-born and U.S.-born cluster members was
established in 9 (20%) of the clustered TB patients with epide-
miologic connections; however, to fully examine the extent
that U.S.-born and foreign-born TB patients transmit TB in
Massachusetts requires a longitudinal investigation of con-
tacts, which was beyond the scope of this investigation. In
addition, among those not born in the United States, increased
time spent in the United States and clustering appeared to be
related. Thus, TB that developed soon after the arrival of the
foreign-born appeared to have been acquired abroad, and more
of the later onset cases in foreign-born persons appeared to be
due to infection acquired in Massachusetts. 
The comparison between genotype clustering and epidemi-
ologic connection provides evidence that the ability of DNA
fingerprints to differentiate TB strains is limited when there
are few copies of IS6110. Only 37% of the isolates in clusters
containing few copies of IS6110 had their TB strain differenti-
ated further by spoligotyping. Examination of clustered TB
patients with no epidemiologic links indicated that two thirds
had few copies of IS6110. Epidemiologic connections were
more often discovered when the clusters involved U.S.-born
TB patients. Despite the use of interpreters, we may have been
less successful in obtaining epidemiologic relationship infor-
mation from foreign-born patients than from U.S.-born
patients because of language and cultural barriers. However,
even in the clusters of the U.S.-born patients, in which lan-
guage was not an issue, epidemiologic connections could not
be found in clusters with few RFLP bands. This suggests that
the use of RFLP analysis, even with spoligotyping, may not be
powerful enough to identify true clustering among isolates
with few copies of IS6110.
The drawbacks to the RFLP technique include the follow-
ing: it is labor-intensive, requires culture growth, is difficult to
reproduce, and can require laborious secondary typing tech-
niques (7,8,12). Other genotyping techniques, such as myco-
bacterial interspersed repetitive units–variable number of
tandem repeats, are being considered that may offer advan-
Table 3: Mycobacterium tuberculosis IS6110 copy numbers in geno-
types by geographic region
Geographic 
region
No. of isolates 
in foreign-born 
(%) (n=684)
Containing > 6 
copies of  IS6110 (%)
Containing <6 
copies of 
IS6110 (%)
Asia 295 194 (66) 101 (34)
China 59 52 (88) 7 (12)
India 54 34 (63) 20 (37)
Vietnam 87 45 (52) 42 (48)
Other 95 63 (66) 32 (34)
Caribbean 118 111 (94) 7 (6)
Dominican Rep 30 30 (100) 0
Haiti 83 76 (92) 7 (8)
Other 5 5 (100) 0 
Africa 116 97 (84) 19 (16)
Europe 59 55 (93) 4 (7)
South America  47 45 (96) 2 (4)
Central  America 41 36 (88) 5 (12)
Other a 8 5 (57) 3 (43)
aOther, 7 patients from Canada and 1 patient from Australia.
Table 4. Molecular clustering of tuberculosis (TB) cases among foreign-born persons by time to TB diagnosis after arrival in the United States
Time to TB diagnosis Cluster (%) Nonclustered (%) Odds ratio and 95% confidence interval (CI) Chi square for trend a 
<1 year of arrival 29 (16)) 148 (84) 1.0 6.31 p =.012
1–5 years of arrival 38 (22) 139 (78) 1.40 (95% CI 0.79,2.47)
>5 years of arrival  86 (26) 244 (74) 1.80 (95% CI 1.10, 2.95)
Total 153 (22) 531 (78)
aStatistically significant trend for overall link based on country of origin was observed at p<0.05TUBERCULOSIS GENOTYPING NETWORK
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tages, including rapid turnaround time for results, reproduc-
ibility, and high sensitivity and specificity for M. tuberculosis.
However, those methods may have less discriminating power
than RFLP (7,12). Analyses of distribution and clustering of
RFLP patterns may provide information regarding the ability
of RFLP and other possible DNA fingerprinting methods to
differentiate TB strains within various communities. For
example, our analysis suggests that the ability of DNA finger-
printing to differentiate TB strains in the Asian community
may be limited because one third of the isolates contained few
copies of IS6110, and the secondary fingerprinting technique
had less discriminatory power (Table 3).
Some limitations of the study must be noted. First, in
RFLP analysis, the usual turnaround time between specimen
collection and availability of result is lengthy (7,8). In some
years, our turnaround time averaged 8 months. This lag time
hindered the program’s ability to locate clustered patients for
interview and affected the patients’ ability to recall contacts,
and thus could have contributed to the relatively low percent-
age of completed interviews (65%). Of 56 patients eligible for
interviews, 41% were lost to follow-up or had moved out of
state.
Other limitations include the lack of specificity to differen-
tiate TB strains with few copies of IS6110 (7) and incomplete
sampling (13). An overestimation of genetic clustering, partic-
ularly among isolates with few copies of IS6110, may have
occurred. On the other hand, clustered TB patients may have
been underestimated because possible clonal relationships of
isolates from our study population may have existed with
patients reported outside of Massachusetts or outside the study
time frame. In addition, a certain number of isolates in every
population are unable to be given RFLP types.
Conclusions
Molecular fingerprint data were useful in describing the
epidemiology of TB in Massachusetts. Using this information,
the TB Division can estimate TB patients that resulted from
transmission in this state and design appropriate interventions.
However, the capacity of DNA fingerprinting data to differen-
tiate TB stains may vary by community of interest, and RFLP
analysis, even with secondary typing, may not identify true
clusters when isolates have few copies of IS6110. This situa-
tion has implications for genotyping techniques that have less
discriminatory power than RFLP analysis. DNA fingerprinting
should therefore be used in conjunction with effective surveil-
lance and appropriate epidemiologic investigation.
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